A detailed history of Washington Trust CO transactions in Merck & Co., Inc. stock. As of the latest transaction made, Washington Trust CO holds 31,109 shares of MRK stock, worth $3.11 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
31,109
Previous 33,089 5.98%
Holding current value
$3.11 Million
Previous $4.1 Million 13.77%
% of portfolio
0.12%
Previous 0.15%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

SELL
$111.15 - $128.97 $220,077 - $255,360
-1,980 Reduced 5.98%
31,109 $3.53 Million
Q2 2024

Jul 15, 2024

SELL
$123.8 - $132.96 $187,433 - $201,301
-1,514 Reduced 4.38%
33,089 $4.1 Million
Q1 2024

Apr 23, 2024

BUY
$113.24 - $131.95 $12,229 - $14,250
108 Added 0.31%
34,603 $4.57 Million
Q4 2023

Jan 18, 2024

SELL
$100.18 - $109.02 $81,145 - $88,306
-810 Reduced 2.29%
34,495 $3.76 Million
Q3 2023

Oct 18, 2023

SELL
$102.95 - $114.33 $25,634 - $28,468
-249 Reduced 0.7%
35,305 $3.63 Million
Q2 2023

Jul 27, 2023

BUY
$108.61 - $118.38 $22,916 - $24,978
211 Added 0.6%
35,554 $4.1 Million
Q1 2023

May 10, 2023

BUY
$102.94 - $114.86 $3.73 Million - $4.16 Million
36,199 Added 100552.78%
36,235 $3.86 Million
Q1 2023

May 04, 2023

SELL
$102.94 - $114.86 $3.63 Million - $4.06 Million
-35,307 Reduced 99.9%
36 $3.86 Million
Q4 2022

Jul 27, 2023

SELL
$87.44 - $112.11 $77,996 - $100,002
-892 Reduced 2.46%
35,343 $3.92 Million
Q4 2022

Feb 08, 2023

SELL
$87.44 - $112.11 $51,152 - $65,584
-585 Reduced 1.63%
35,343 $3.92 Million
Q3 2022

Oct 14, 2022

BUY
$84.53 - $94.96 $60,608 - $68,086
717 Added 2.04%
35,928 $3.1 Million
Q2 2022

Jul 25, 2022

BUY
$83.49 - $94.64 $99,186 - $112,432
1,188 Added 3.49%
35,211 $3.21 Million
Q1 2022

May 05, 2022

BUY
$73.51 - $82.4 $42,341 - $47,462
576 Added 1.72%
34,023 $2.79 Million
Q4 2021

Feb 09, 2022

SELL
$72.28 - $90.54 $713,981 - $894,354
-9,878 Reduced 22.8%
33,447 $2.56 Million
Q3 2021

Nov 09, 2021

SELL
$71.68 - $78.83 $58,920 - $64,798
-822 Reduced 1.86%
43,325 $3.25 Million
Q2 2021

Aug 05, 2021

SELL
$70.31 - $77.77 $60,185 - $66,571
-856 Reduced 1.9%
44,147 $3.43 Million
Q1 2021

Apr 28, 2021

SELL
$68.86 - $81.11 $13,496 - $15,897
-196 Reduced 0.43%
45,003 $3.47 Million
Q4 2020

Feb 09, 2021

BUY
$71.77 - $79.65 $29,497 - $32,736
411 Added 0.92%
45,199 $3.7 Million
Q3 2020

Nov 05, 2020

SELL
$73.18 - $82.95 $102,964 - $116,710
-1,407 Reduced 3.05%
44,788 $3.72 Million
Q2 2020

Aug 04, 2020

SELL
$70.42 - $80.13 $1.75 Million - $1.99 Million
-24,891 Reduced 35.02%
46,195 $3.53 Million
Q1 2020

May 07, 2020

BUY
$63.36 - $87.82 $145,791 - $202,073
2,301 Added 3.35%
71,086 $5.47 Million
Q4 2019

Feb 12, 2020

BUY
$77.58 - $87.54 $488,210 - $550,889
6,293 Added 10.07%
68,785 $6.26 Million
Q3 2019

Nov 06, 2019

SELL
$76.08 - $82.93 $24,117 - $26,288
-317 Reduced 0.5%
62,492 $5.42 Million
Q2 2019

Aug 07, 2019

SELL
$69.84 - $81.59 $12,361 - $14,441
-177 Reduced 0.28%
62,809 $5.27 Million
Q1 2019

May 13, 2019

SELL
$69.58 - $79.36 $465,211 - $530,600
-6,686 Reduced 9.6%
62,986 $4.92 Million
Q4 2018

Feb 11, 2019

SELL
$65.24 - $75.71 $382,632 - $444,039
-5,865 Reduced 7.76%
69,672 $5.32 Million
Q3 2018

Nov 13, 2018

SELL
$57.69 - $67.84 $19,095 - $22,455
-331 Reduced 0.44%
75,537 $5.36 Million
Q2 2018

Aug 10, 2018

BUY
$50.83 - $59.72 $1.49 Million - $1.75 Million
29,362 Added 63.14%
75,868 $4.61 Million
Q1 2018

May 10, 2018

SELL
$50.96 - $59.23 $16,409 - $19,072
-322 Reduced 0.69%
46,506 $2.53 Million
Q4 2017

Feb 05, 2018

BUY
$51.62 - $61.64 $22,041 - $26,320
427 Added 0.92%
46,828 $2.64 Million
Q3 2017

Oct 31, 2017

BUY
$58.67 - $63.13 $2.72 Million - $2.93 Million
46,401
46,401 $2.97 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $253B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Washington Trust CO Portfolio

Follow Washington Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Washington Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Washington Trust CO with notifications on news.